acetylcysteine has been researched along with Respiratory Syndrome, Acute, Severe in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Corn, J; Poe, FL | 1 |
Wu, J | 1 |
Bhattacharyya, S; Fossum, C; Hati, S; Johnson, B; Laatsch, B; Liebau, J; Lowater, H; McCracken, C; Narkiewicz-Jodko, A; Severson, N; Suhail, S; Zajac, J | 1 |
2 review(s) available for acetylcysteine and Respiratory Syndrome, Acute, Severe
Article | Year |
---|---|
Tackle the free radicals damage in COVID-19.
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Azithromycin; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Therapy, Combination; Free Radicals; Glutathione; Humans; Hydroxychloroquine; Mice; Multiple Organ Failure; NF-E2-Related Factor 2; Nitric Oxide; Orthomyxoviridae Infections; Oxidative Stress; Pandemics; Pneumonia, Viral; Reactive Oxygen Species; SARS-CoV-2; Severe Acute Respiratory Syndrome | 2020 |
Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review.
Topics: Acetylcysteine; Angiotensin-Converting Enzyme 2; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Humans; Models, Molecular; Oxidative Stress; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Viral Envelope Proteins | 2020 |
1 other study(ies) available for acetylcysteine and Respiratory Syndrome, Acute, Severe
Article | Year |
---|---|
N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2.
Topics: Acetylcysteine; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Free Radicals; Glutathione; Humans; Inflammation; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidation-Reduction; Oxidative Stress; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome; T-Lymphocytes; Tumor Necrosis Factor-alpha; Viral Load | 2020 |